FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2926804536> ?p ?o ?g. }

• W2926804536 endingPage "5" @default.
• W2926804536 startingPage "1" @default.
• W2926804536 abstract "Many patients who were diagnosed as polycystic ovary syndrome- (PCOS-) related acne were not capable of sustaining or beginning oral contraceptive pills (OCPs) due to pill scaring, contraindications of OCP use, migraine, or smoking. In this situation, oral isotretinoin treatment may become an important option for PCOS-related acne. The aim of the study was to determine the effects of isotretinoin treatment on PCOS patients who were complicated with severe cystic acne.This study consisted of 40 female patients diagnosed as PCOS complicated with severe cystic acne. These patients were not eligible candidates for OCP use due to migraine, thrombophilia, heavy smoking, or pill scare. To establish baseline values of hormone levels, on days 2-5 of the menstrual cycle, venous blood samples were obtained. Moreover Modified Ferriman-Gallwey (mFG) score, acne score (AS), follicle count, and bilateral ovarian volumes were evaluated both before and after isotretinoin treatment.Isotretinoin treatment significantly decreased Ferriman-Gallwey score, free testosterone, insulin level, hemoglobin level, acne score, and ovarian volume. Increased triglyceride and cholesterol levels were detected after treatment.Isotretinoin treatment may have beneficial effects on free testosterone, insulin, acne score, and Ferriman-Gallwey score. Solely isotretinoin administration may supply adequate healing in PCOS patients' symptoms complicated with severe cystic acne who is not eligible candidates for OCP use. This trial is registered with Clinicaltrials.gov NCT02855138." @default.
• W2926804536 created "2019-04-11" @default.
• W2926804536 creator A5010179396 @default.
• W2926804536 creator A5013294014 @default.
• W2926804536 creator A5021933199 @default.
• W2926804536 creator A5025907570 @default.
• W2926804536 creator A5031330860 @default.
• W2926804536 creator A5038529783 @default.
• W2926804536 creator A5039918137 @default.
• W2926804536 creator A5086997376 @default.
• W2926804536 creator A5089002310 @default.
• W2926804536 date "2019-04-07" @default.
• W2926804536 modified "2023-10-09" @default.
• W2926804536 title "The Effects of Oral Isotretinoin in Women with Acne and Polycystic Ovary Syndrome" @default.
• W2926804536 cites W165462166 @default.
• W2926804536 cites W1842122027 @default.
• W2926804536 cites W1913360749 @default.
• W2926804536 cites W1917024515 @default.
• W2926804536 cites W1921351123 @default.
• W2926804536 cites W1969066867 @default.
• W2926804536 cites W1971284794 @default.
• W2926804536 cites W1973396327 @default.
• W2926804536 cites W2010282242 @default.
• W2926804536 cites W2023821135 @default.
• W2926804536 cites W2033518906 @default.
• W2926804536 cites W2043738753 @default.
• W2926804536 cites W2079644793 @default.
• W2926804536 cites W2079804506 @default.
• W2926804536 cites W2091449173 @default.
• W2926804536 cites W2092997557 @default.
• W2926804536 cites W2107500974 @default.
• W2926804536 cites W2114876293 @default.
• W2926804536 cites W2153191427 @default.
• W2926804536 cites W2162365554 @default.
• W2926804536 cites W2285307649 @default.
• W2926804536 cites W2410918233 @default.
• W2926804536 cites W2508306553 @default.
• W2926804536 cites W2528232411 @default.
• W2926804536 cites W2566703296 @default.
• W2926804536 cites W2745377850 @default.
• W2926804536 cites W2755770006 @default.
• W2926804536 cites W2888477383 @default.
• W2926804536 cites W2894361715 @default.
• W2926804536 cites W4256605237 @default.
• W2926804536 doi "https://doi.org/10.1155/2019/2513067" @default.
• W2926804536 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6475563" @default.
• W2926804536 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31080813" @default.
• W2926804536 hasPublicationYear "2019" @default.
• W2926804536 type Work @default.
• W2926804536 sameAs 2926804536 @default.
• W2926804536 citedByCount "19" @default.
• W2926804536 countsByYear W29268045362020 @default.
• W2926804536 countsByYear W29268045362021 @default.
• W2926804536 countsByYear W29268045362022 @default.
• W2926804536 countsByYear W29268045362023 @default.
• W2926804536 crossrefType "journal-article" @default.
• W2926804536 hasAuthorship W2926804536A5010179396 @default.
• W2926804536 hasAuthorship W2926804536A5013294014 @default.
• W2926804536 hasAuthorship W2926804536A5021933199 @default.
• W2926804536 hasAuthorship W2926804536A5025907570 @default.
• W2926804536 hasAuthorship W2926804536A5031330860 @default.
• W2926804536 hasAuthorship W2926804536A5038529783 @default.
• W2926804536 hasAuthorship W2926804536A5039918137 @default.
• W2926804536 hasAuthorship W2926804536A5086997376 @default.
• W2926804536 hasAuthorship W2926804536A5089002310 @default.
• W2926804536 hasBestOaLocation W29268045361 @default.
• W2926804536 hasConcept C126322002 @default.
• W2926804536 hasConcept C16005928 @default.
• W2926804536 hasConcept C2776285725 @default.
• W2926804536 hasConcept C2776371013 @default.
• W2926804536 hasConcept C2777391703 @default.
• W2926804536 hasConcept C2777673923 @default.
• W2926804536 hasConcept C2778212516 @default.
• W2926804536 hasConcept C2779076696 @default.
• W2926804536 hasConcept C2779306644 @default.
• W2926804536 hasConcept C2908647359 @default.
• W2926804536 hasConcept C29456083 @default.
• W2926804536 hasConcept C2986817661 @default.
• W2926804536 hasConcept C3018442814 @default.
• W2926804536 hasConcept C71924100 @default.
• W2926804536 hasConcept C81603835 @default.
• W2926804536 hasConcept C98274493 @default.
• W2926804536 hasConcept C99454951 @default.
• W2926804536 hasConceptScore W2926804536C126322002 @default.
• W2926804536 hasConceptScore W2926804536C16005928 @default.
• W2926804536 hasConceptScore W2926804536C2776285725 @default.
• W2926804536 hasConceptScore W2926804536C2776371013 @default.
• W2926804536 hasConceptScore W2926804536C2777391703 @default.
• W2926804536 hasConceptScore W2926804536C2777673923 @default.
• W2926804536 hasConceptScore W2926804536C2778212516 @default.
• W2926804536 hasConceptScore W2926804536C2779076696 @default.
• W2926804536 hasConceptScore W2926804536C2779306644 @default.
• W2926804536 hasConceptScore W2926804536C2908647359 @default.
• W2926804536 hasConceptScore W2926804536C29456083 @default.
• W2926804536 hasConceptScore W2926804536C2986817661 @default.
• W2926804536 hasConceptScore W2926804536C3018442814 @default.
• W2926804536 hasConceptScore W2926804536C71924100 @default.
• W2926804536 hasConceptScore W2926804536C81603835 @default.

• next